Categories
Anthem Biosciences Limited — Updates, 19-05-2026: General Updates
19-05-2026 · 08:00 pm
Anthem Biosciences disclosed strong FY26 KPIs: Total Revenue grew 15.17% YoY to ₹2,124 Cr. EBITDA surged 31.21% to ₹897 Cr (47.07% margin), and PAT jumped 31.14% to ₹592 Cr (25.95% margin). CRDMO contributed 83% of revenue.
No comments yet. Be the first to comment!